Tirzepatide Peptide Agonist Targeting GIP And GLP-1 Receptors Freeze Dried Form
TDS 2100 Inquiries
2023788-19-2
Cosmetics Grade
99%
guangzhou
chunqiao
10 Vials per kit
Yes
2026-11-16
peptide
-
Product Details
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Certificates-
TDS
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide
-
Location:
Unit 1-B2141, 19B-F1, 81-1 Nonglinxia Road, Yuexiu District, Guangzhou, China
-
Payment Terms:
100% TT in advance
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History2100 Inquiries
Country Product Purchase Quantity Date Posted
United States
Tirzepatide
60 MG Oct 28, 2026
United States
Tirzepatide
10 PCS Oct 28, 2026
United States
tirzepatide
30 MG Oct 27, 2026
United States
Tirzepatide
40 MG Oct 27, 2026
Philippines
Tirzepatide
2 MT Oct 27, 2026
Philippines
Tirzepatide
30 MG Oct 26, 2026
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026
United States
Tirzepatide
50 MG Oct 20, 2026
Spain
tirzepatide
20 MG Oct 19, 2026
United States
tirzepatide
30 MG Oct 19, 2026 Post an enquiry for this product
More from this Seller
-
-
-
KPV Anti Inflammatory Tripeptide Research Mixture For Gut Immune Cell Culture Experiment
Cosmetics Grade / 99%
$45/UNIT FOB
-
-
-
-
Products -Retatrutid- Purity up to 99% peptide-
Pharmaceutical Grade / 99%
-
-
-
-
LL-37 Pathogen Defensive Peptide Research Mixture For Skin Wound Cell Culture Experiment
Cosmetics Grade / 99%
$100/UNIT FOB
-
-
-
-
Thymosin Alpha-1 Thymic Immunopeptide Substance For Lymphocyte Activation Assessment
Cosmetics Grade / 99%
$55/UNIT FOB
-
-
-
-
Top Grade Best Peptide,99% High Purity Level white raw powder in stock 100mg
Pharmaceutical Grade / 99.9%
-
